Early research (Phase 1)Ended earlyNCT05069935What this trial is testingFT538 in Combination With Monoclonal Antibodies in Advanced Solid TumorsWho this might be right forSolid Tumor, Adult Fate Therapeutics 16
Large-scale testing (Phase 3)Not Yet RecruitingNCT07251062What this trial is testingSYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma.Who this might be right forEsophageal Squamous Cell Carcinoma CSPC Megalith Biopharmaceutical Co.,Ltd. 737
Testing effectiveness (Phase 2)Study completedNCT02350517What this trial is testingEndostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal CancerWho this might be right forEsophageal Squamous Cell Carcinoma Yuhong Li 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 798
Early research (Phase 1)Study completedNCT00030498What this trial is testingErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more National Cancer Institute (NCI) 75
Large-scale testing (Phase 3)UnknownNCT05737563What this trial is testingPD-1 Antibody Combined With mXELIRI Versus mXELIRI in the Second-line Setting for ESCCWho this might be right forEsophageal Squamous Cell Carcinoma Abdominal Stage 0 Sun Yat-sen University 380
Large-scale testing (Phase 3)Looking for participantsNCT06138028What this trial is testingSintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal CancerWho this might be right forMetastatic Esophageal Squamous Cell Carcinoma Qingdao Central Hospital 90
Early research (Phase 1)Not Yet RecruitingNCT07807345What this trial is testingPhase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or MetastaticWho this might be right forHead & Neck Squamous Cell CarcinomaNon-Small Cell Lung CancerEsophageal Cancer+5 more Sutro Biopharma, Inc. 285
Not applicableNot Yet RecruitingNCT07822906What this trial is testingRisk of Esophageal Cancer Returning After Immunotherapy, Chemotherapy, and SurgeryWho this might be right forEsophageal Squamous Cell Carcinoma (ESCC) Peking University Cancer Hospital & Institute 100
Large-scale testing (Phase 3)Study completedNCT02564263What this trial is testingStudy of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/ Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)Who this might be right forEsophageal CarcinomaEsophagogastric Junction Carcinoma Merck Sharp & Dohme LLC 628
Early research (Phase 1)UnknownNCT05927844What this trial is testingXH-30002 Capsule Combined With Afatinib Tablets for the Treatment of Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma Fujian Cancer Hospital 20
Early research (Phase 1)Study completedNCT04925284What this trial is testingStudy of XB002 in Subjects With Solid Tumors (JEWEL-101)Who this might be right forNon Small Cell Lung CancerCervical CancerSCCHN+8 more Exelixis 269
Testing effectiveness (Phase 2)Study completedNCT03212469What this trial is testingA Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic CancerWho this might be right forHead and Neck Squamous Cell CarcinomaLung CancerOesophageal Cancer Gustave Roussy, Cancer Campus, Grand Paris 54
Large-scale testing (Phase 3)Looking for participantsNCT07554456What this trial is testingBL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizumab as First-line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus02)Who this might be right forEsophageal Squamous Cell Carcinoma Sichuan Baili Pharmaceutical Co., Ltd. 90
Testing effectiveness (Phase 2)Study completedNCT00003103What this trial is testingChemotherapy in Treating Patients With Solid TumorsWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Memorial Sloan Kettering Cancer Center 57
Testing effectiveness (Phase 2)Looking for participantsNCT07602842What this trial is testingIDP-001 in Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorMetastatic Solid TumorHead and Neck Squamous Cell Carcinoma+6 more InduPro, Inc. 132
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06703047What this trial is testingTislelizumab Combined with Chemotherapy and All Trans Retinoic Acid for Locally Advanced or Metastatic Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma Fudan University 180
Testing effectiveness (Phase 2)Ended earlyNCT03829501What this trial is testingA Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced MalignanciesWho this might be right forSquamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular Carcinoma+9 more Kymab Limited 222
Large-scale testing (Phase 3)UnknownNCT02375997What this trial is testingEarly Palliative Care in Metastatic Esophageal Squamous Carcinoma (ESCC) and Gastric CancerWho this might be right forMetastatic Esophageal Squamous CarcinomaGastric Cancer Peking University 592
Early research (Phase 1)Study completedNCT00397384What this trial is testingErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more National Cancer Institute (NCI) 43